長高集團(002452.SZ):含實控人在內5名董高擬提前終止減持計劃 已減持合計1226.45萬股
格隆匯3月7日丨長高集團(002452.SZ)公佈,2022年3月7日,公司收到實際控制人、董事長馬孝武、董事馬曉、林林、劉家鈺、財務總監劉雲強五人分別出具的《關於股份減持計劃實施進展暨提前終止減持計劃的吿知函》。上述股東基於自身原因,決定提前終止本次減持計劃,未完成減持的股份在本次減持計劃期間內將不再減持。
減持期間,馬孝武累計減持1009.08萬股,馬曉累計減持110萬股,林林累計減持75.47萬股,劉家鈺累計減持28萬股,劉雲強累計減持3.9萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.